by Julia Samuel on  February 6, 2017 at 3:20 PM Health Watch
  • Measles Rubella (MR) vaccination campaign is targeted to reach 41 crore children in India.
  • The new vaccine will replace the two doses of measles vaccines given at 9-12 months and 16-24 months of age.
  • The vaccine protects against two deadly diseases—measles and rubella, only preventable through vaccination.

New Measles Rubella Vaccine Used in The Mass Campaign in India
A new Measles Rubella (MR) vaccine, will replace the current two doses given at 9-12 months and 16-24 months of age, and will offer dual protection, against measles and rubella.

The first phase of Measles Rubella (MR) vaccination campaign will begin in Karnataka, Tamil Nadu, Puducherry, Goa and Lakshadweep, covering nearly 3.6 crore target children.

Measles is a deadly disease and one of the important causes of death in children. It is highly contagious and spreads through coughing and sneezing by an infected person. Measles can make a child vulnerable to life threatening complications such as pneumonia, diarrhea and brain infection.

Rubella is generally a mild infection, but has serious consequences if the infection occurs in pregnant women, causing congenital rubella syndrome (CRS), which is a cause of public health concern.

CRS is characterized by congenital anomalies in the fetus and newborns affecting the eyes (glaucoma, cataract), ears (hearing loss), brain (microcephaly, mental retardation) and heart defects, causing a huge socio-economic burden on the families in particular and society in general.

"This campaign will be taken up in a mission mode and has been rolled out in partnership with States, NGOs and development partners such as WHO, UNICEF, Gates Foundation, Lions Club, IPA, IMA. As part of a nationwide campaign, the health ministry will reach out to and cover 41 crore children, the largest ever in any campaign," Faggan Singh Kulaste, Minister of State for Health and Family Welfare said.

"Children in the age group of 9 months to 15 years will be given a single shot of MR vaccination irrespective of their previous measles/rubella vaccination status or measles/rubella disease status," he said. The vaccine will be provided free of cost across the States from session sites at schools and health facilities and outreach session sites.

"The vaccine protects against two deadly diseases—measles and rubella, only preventable through vaccination. There is no specific treatment for the diseases. MR vaccination is an essential investment by the government in children's lives and will ensure that as future healthy citizens they contribute to the development of the country," said Dr Yaron Wolman, Chief of Health, UNICEF India.

After the completion of the campaign, MR vaccine will be introduced in routine immunization and will replace measles vaccine, given at 9-12 months and 16-24 months of age of child.

Source: Medindia

Most Popular on Medindia